| Edgewater Orthopedic Physical Therapy, Llc | |
|
98 Clearwater Dr, Suite 3, Falmouth, ME 04105 | |
| (207) 781-9885 | |
| Not Available |
| Full Name | Edgewater Orthopedic Physical Therapy, Llc |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist |
| Location | 98 Clearwater Dr, Falmouth, Maine |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053518332 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 3114 (Maine) | Primary |
| Provider Name | Jill E Pelletier |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1770693350 PECOS PAC ID: 7214024264 Enrollment ID: I20071107000557 |
News Archive
A study led by researchers from Plymouth University Peninsula Schools of Medicine and Dentistry has for the first time revealed how the loss of a particular tumour suppressing protein leads to the abnormal growth of tumours of the brain and nervous system.
The U.S. Food and Drug Administration has approved Besivance (besifloxacin ophthalmic suspension 0.6 percent) for the treatment of bacterial conjunctivitis (non-viral), a contagious condition marked by irritation of the eyes and a discharge from the mucous membranes.
A new MR procedure that uses diffusion-weighted imaging (DWI) to determine whether or not a breast lesion is malignant or benign may help reduce unnecessary breast biopsies, according to a study performed at the National Institute of Health in Bethesda, MD.
"Charged by Secretary of State Hillary Clinton with developing a blueprint for the next phase of the U.S. government's involvement in the fight against HIV and AIDS, [U.S. Global AIDS Coordinator Ambassador Eric Goosby] ... will lead an interagency effort to give clearer meaning to the term, 'AIDS-free generation,' and provide a basis for programming," Sharon Stash, a senior fellow at the Center for Strategic & International Studies' (CSIS) Global Health Policy Center, writes in the CSIS "Smart Global Health" blog.
› Verified 2 days ago
| Provider Name | Heidi Batchelder |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1255356226 PECOS PAC ID: 4981764594 Enrollment ID: I20081126000348 |
News Archive
A study led by researchers from Plymouth University Peninsula Schools of Medicine and Dentistry has for the first time revealed how the loss of a particular tumour suppressing protein leads to the abnormal growth of tumours of the brain and nervous system.
The U.S. Food and Drug Administration has approved Besivance (besifloxacin ophthalmic suspension 0.6 percent) for the treatment of bacterial conjunctivitis (non-viral), a contagious condition marked by irritation of the eyes and a discharge from the mucous membranes.
A new MR procedure that uses diffusion-weighted imaging (DWI) to determine whether or not a breast lesion is malignant or benign may help reduce unnecessary breast biopsies, according to a study performed at the National Institute of Health in Bethesda, MD.
"Charged by Secretary of State Hillary Clinton with developing a blueprint for the next phase of the U.S. government's involvement in the fight against HIV and AIDS, [U.S. Global AIDS Coordinator Ambassador Eric Goosby] ... will lead an interagency effort to give clearer meaning to the term, 'AIDS-free generation,' and provide a basis for programming," Sharon Stash, a senior fellow at the Center for Strategic & International Studies' (CSIS) Global Health Policy Center, writes in the CSIS "Smart Global Health" blog.
› Verified 2 days ago
| Provider Name | Karen R Proctor |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1053386854 PECOS PAC ID: 5092986422 Enrollment ID: I20110915000485 |
News Archive
A study led by researchers from Plymouth University Peninsula Schools of Medicine and Dentistry has for the first time revealed how the loss of a particular tumour suppressing protein leads to the abnormal growth of tumours of the brain and nervous system.
The U.S. Food and Drug Administration has approved Besivance (besifloxacin ophthalmic suspension 0.6 percent) for the treatment of bacterial conjunctivitis (non-viral), a contagious condition marked by irritation of the eyes and a discharge from the mucous membranes.
A new MR procedure that uses diffusion-weighted imaging (DWI) to determine whether or not a breast lesion is malignant or benign may help reduce unnecessary breast biopsies, according to a study performed at the National Institute of Health in Bethesda, MD.
"Charged by Secretary of State Hillary Clinton with developing a blueprint for the next phase of the U.S. government's involvement in the fight against HIV and AIDS, [U.S. Global AIDS Coordinator Ambassador Eric Goosby] ... will lead an interagency effort to give clearer meaning to the term, 'AIDS-free generation,' and provide a basis for programming," Sharon Stash, a senior fellow at the Center for Strategic & International Studies' (CSIS) Global Health Policy Center, writes in the CSIS "Smart Global Health" blog.
› Verified 2 days ago
| Provider Name | Margaret Masiak Beliveau |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1760935233 PECOS PAC ID: 9032406533 Enrollment ID: I20160927002774 |
News Archive
A study led by researchers from Plymouth University Peninsula Schools of Medicine and Dentistry has for the first time revealed how the loss of a particular tumour suppressing protein leads to the abnormal growth of tumours of the brain and nervous system.
The U.S. Food and Drug Administration has approved Besivance (besifloxacin ophthalmic suspension 0.6 percent) for the treatment of bacterial conjunctivitis (non-viral), a contagious condition marked by irritation of the eyes and a discharge from the mucous membranes.
A new MR procedure that uses diffusion-weighted imaging (DWI) to determine whether or not a breast lesion is malignant or benign may help reduce unnecessary breast biopsies, according to a study performed at the National Institute of Health in Bethesda, MD.
"Charged by Secretary of State Hillary Clinton with developing a blueprint for the next phase of the U.S. government's involvement in the fight against HIV and AIDS, [U.S. Global AIDS Coordinator Ambassador Eric Goosby] ... will lead an interagency effort to give clearer meaning to the term, 'AIDS-free generation,' and provide a basis for programming," Sharon Stash, a senior fellow at the Center for Strategic & International Studies' (CSIS) Global Health Policy Center, writes in the CSIS "Smart Global Health" blog.
› Verified 2 days ago
| Provider Name | Sarah J Kain |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1457704918 PECOS PAC ID: 2264797372 Enrollment ID: I20180521000085 |
News Archive
A study led by researchers from Plymouth University Peninsula Schools of Medicine and Dentistry has for the first time revealed how the loss of a particular tumour suppressing protein leads to the abnormal growth of tumours of the brain and nervous system.
The U.S. Food and Drug Administration has approved Besivance (besifloxacin ophthalmic suspension 0.6 percent) for the treatment of bacterial conjunctivitis (non-viral), a contagious condition marked by irritation of the eyes and a discharge from the mucous membranes.
A new MR procedure that uses diffusion-weighted imaging (DWI) to determine whether or not a breast lesion is malignant or benign may help reduce unnecessary breast biopsies, according to a study performed at the National Institute of Health in Bethesda, MD.
"Charged by Secretary of State Hillary Clinton with developing a blueprint for the next phase of the U.S. government's involvement in the fight against HIV and AIDS, [U.S. Global AIDS Coordinator Ambassador Eric Goosby] ... will lead an interagency effort to give clearer meaning to the term, 'AIDS-free generation,' and provide a basis for programming," Sharon Stash, a senior fellow at the Center for Strategic & International Studies' (CSIS) Global Health Policy Center, writes in the CSIS "Smart Global Health" blog.
› Verified 2 days ago
| Provider Name | Sarah K Richardson |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1588119366 PECOS PAC ID: 0547505281 Enrollment ID: I20181227000636 |
News Archive
A study led by researchers from Plymouth University Peninsula Schools of Medicine and Dentistry has for the first time revealed how the loss of a particular tumour suppressing protein leads to the abnormal growth of tumours of the brain and nervous system.
The U.S. Food and Drug Administration has approved Besivance (besifloxacin ophthalmic suspension 0.6 percent) for the treatment of bacterial conjunctivitis (non-viral), a contagious condition marked by irritation of the eyes and a discharge from the mucous membranes.
A new MR procedure that uses diffusion-weighted imaging (DWI) to determine whether or not a breast lesion is malignant or benign may help reduce unnecessary breast biopsies, according to a study performed at the National Institute of Health in Bethesda, MD.
"Charged by Secretary of State Hillary Clinton with developing a blueprint for the next phase of the U.S. government's involvement in the fight against HIV and AIDS, [U.S. Global AIDS Coordinator Ambassador Eric Goosby] ... will lead an interagency effort to give clearer meaning to the term, 'AIDS-free generation,' and provide a basis for programming," Sharon Stash, a senior fellow at the Center for Strategic & International Studies' (CSIS) Global Health Policy Center, writes in the CSIS "Smart Global Health" blog.
› Verified 2 days ago
| Provider Name | Alyssa House |
|---|---|
| Provider Type | Practitioner - Physical Medicine And Rehabilitation |
| Provider Identifiers | NPI Number: 1205463007 PECOS PAC ID: 6608206065 Enrollment ID: I20220729001854 |
News Archive
A study led by researchers from Plymouth University Peninsula Schools of Medicine and Dentistry has for the first time revealed how the loss of a particular tumour suppressing protein leads to the abnormal growth of tumours of the brain and nervous system.
The U.S. Food and Drug Administration has approved Besivance (besifloxacin ophthalmic suspension 0.6 percent) for the treatment of bacterial conjunctivitis (non-viral), a contagious condition marked by irritation of the eyes and a discharge from the mucous membranes.
A new MR procedure that uses diffusion-weighted imaging (DWI) to determine whether or not a breast lesion is malignant or benign may help reduce unnecessary breast biopsies, according to a study performed at the National Institute of Health in Bethesda, MD.
"Charged by Secretary of State Hillary Clinton with developing a blueprint for the next phase of the U.S. government's involvement in the fight against HIV and AIDS, [U.S. Global AIDS Coordinator Ambassador Eric Goosby] ... will lead an interagency effort to give clearer meaning to the term, 'AIDS-free generation,' and provide a basis for programming," Sharon Stash, a senior fellow at the Center for Strategic & International Studies' (CSIS) Global Health Policy Center, writes in the CSIS "Smart Global Health" blog.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Edgewater Orthopedic Physical Therapy, Llc 74 Vesper St, Portland, ME 04101-4432 Ph: () - | Edgewater Orthopedic Physical Therapy, Llc 98 Clearwater Dr, Suite 3, Falmouth, ME 04105 Ph: (207) 781-9885 |
News Archive
A study led by researchers from Plymouth University Peninsula Schools of Medicine and Dentistry has for the first time revealed how the loss of a particular tumour suppressing protein leads to the abnormal growth of tumours of the brain and nervous system.
The U.S. Food and Drug Administration has approved Besivance (besifloxacin ophthalmic suspension 0.6 percent) for the treatment of bacterial conjunctivitis (non-viral), a contagious condition marked by irritation of the eyes and a discharge from the mucous membranes.
A new MR procedure that uses diffusion-weighted imaging (DWI) to determine whether or not a breast lesion is malignant or benign may help reduce unnecessary breast biopsies, according to a study performed at the National Institute of Health in Bethesda, MD.
"Charged by Secretary of State Hillary Clinton with developing a blueprint for the next phase of the U.S. government's involvement in the fight against HIV and AIDS, [U.S. Global AIDS Coordinator Ambassador Eric Goosby] ... will lead an interagency effort to give clearer meaning to the term, 'AIDS-free generation,' and provide a basis for programming," Sharon Stash, a senior fellow at the Center for Strategic & International Studies' (CSIS) Global Health Policy Center, writes in the CSIS "Smart Global Health" blog.
› Verified 2 days ago
Alexander Thoreau Wheelwright, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 325 Us Route 1 Unit A, Falmouth, ME 04105 Phone: 207-781-2741 | |
Integrative Manual Therapy Associates Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 74 Lunt Road, Suite 206, Falmouth, ME 04105 Phone: 207-781-8358 Fax: 207-781-8357 | |
Atlantic Physical Therapy,llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 74 Gray Rd, Falmouth, ME 04105 Phone: 207-797-3006 Fax: 207-797-3002 | |
Sheila Evans Mcmahon, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 9 Falls Rd, Falmouth, ME 04105 Phone: 207-781-6533 | |
Mrs. Theresa Purington Freeman, PT LMT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4 Fundy Rd, Suite 103, Falmouth, ME 04105 Phone: 207-781-6191 | |
Annika Louise Hester, M.P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 367 Us Route 1, Falmouth, ME 04105 Phone: 207-781-5540 Fax: 207-781-5542 |